
The medical technology developer received series D funding from investors including existing backer Tencent, pushing its total funding past $120m.
Illumina helped the digital PCR technology developer secure fresh convertible bond and loan financing that will be used for international expansion and the further development of its platform.
The Texas Medical Center and Cisco-backed healthcare administration platform developer raised series C financing that took its overall funding to $160m.
The surgical robotics developer received $78.3m in funding from investors including New World Development, Lilly Asia Ventures and Meituan's DragonBall Capital fund.
Sony Innovation Fund took part in a series B round for the digital medicine technology developer as it seeks to expand in the UK and US.
Sunshine Insurance took part in the eye-focused gene therapy developer's series C round, which pushed its overall funding past $140m.
Coinbase Ventures contributed to a $55m round for music-focused NFT platform developer Royal while neural search technology developer Jina AI raised $30m in an SAP-backed round.
The neurodegenerative disease therapy developer has set a $100m placeholder target for an offering following $140m in funding from investors including Amgen and Pivotal BioVentures.
Vifor Pharma is snapping up Lundbeck and Baxter-backed vascular drug developer Sanifit for at least $231m while solar project developer SUN Energy closed $25m in funding at a $200m valuation.
Nationwide Ventures participated in a round for the Medicare brokerage made up of $35m in equity financing and a $100m credit facility.